Found 4 matching trials
Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer Progressing After Endocrine Treatment
PHASE2The purpose of the study is to demonstrate clinical efficacy of the investi...
Location
Multiple Locations
Open Label, Dose Escalating Study With Ertumaxomab In Patients With HER-2/Neu Expressing Advanced Solid Tumors
PHASE1Patients with HER2/neu expressing solid tumors progressing after standard t...
Location
Krankenhaus Nordwest
Safety and Efficacy Study of the Trifunctional Antibody Ertumaxomab to Treat Patients With Advanced or Metastatic Breast Cancer
PHASE2The purpose of this study is to determine the safety and efficacy of the in...
Location
Jules Bordet Institute, Free University of Brussels
Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer After Progression on Trastuzumab Therapy
PHASE2This study has the purpose to demonstrate clinical efficacy of the investig...
Location
Multiple Locations